No apparent effect of cidofovir in epidermodysplasia verruciformis.
This paper reports the failure of a patient suffering from Epidermodysplasia verruciformis, characterised by widespread infection of the skin with human papillomaviruses, to respond to topical and systemic treatment with the antiviral agent, Cidofovir, despite its previously demonstrated effectiveness against a range of different papillomavirus-associated conditions.
Preiser
W
W
Department of Virology, Royal Free and University College Medical School, University College London, UK. preiser@wildmail.com
Kapur
N
N
Snoeck
R
R
Groves
R W
RW
Brink
N S
NS
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004819:Epidermodysplasia Verruciformis / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D008297:Male; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D027383:Papillomaviridae; D017211:Treatment Failure
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir